Stock 4521 KAKEN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Kaken Pharmaceutical Co., Ltd.

Equities

4521

JP3207000005

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
3,407 JPY +0.53% Intraday chart for Kaken Pharmaceutical Co., Ltd. -0.21% +1.55%
2023 Kaken Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for Fiscal Year Ending March 31, 2024 CI
2023 Kaken Pharmaceutical Co., Ltd.(TSE:4521) dropped from FTSE All-World Index CI

Business Summary

KAKEN PHARMACEUTICAL CO., LTD. is a Japan-based company engaged in the production and sale of pharmaceutical products. The Company operates in two business segments. The Pharmaceutical segment involves in the manufacture and sale of pharmaceuticals, medical devices and agricultural drugs. The Real Estate segment is engaged in the leasing of real estate.

Number of employees: 1,130

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceutical
96.7 %
73,623 96.8 % 70,562 96.7 % -4.16%
Real Estate
3.3 %
2,410 3.2 % 2,422 3.3 % +0.50%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
100.0 %
76,034 100.0 % 72,984 100.0 % -4.01%

Managers

Managers TitleAgeSince
Hiroyuki Horiuchi PSD
 President 62 84-03-31
Tetsuo Onuma CHM
 Chairman 73 74-03-31
Masashi Suzudo BRD
 Director/Board Member 61 16-03-31
Masahiro Matsuura BRD
 Director/Board Member 54 94-03-31
Seiji Ito IRC
 Investor Relations Contact - -
Naomi Doi AUD
 Comptroller/Controller/Auditor 65 90-03-31
Atsutada Iwamoto AUD
 Comptroller/Controller/Auditor 67 79-03-31

Members of the board

Members of the board TitleAgeSince
Tetsuo Onuma CHM
 Chairman 73 74-03-31
Shoichiro Takagi BRD
 Director/Board Member 63 20-05-31
Hiroyuki Horiuchi PSD
 President 62 84-03-31
Yoshio Tanabe BRD
 Director/Board Member 69 16-05-31
Keiko Kamibeppu BRD
 Director/Board Member 69 19-05-31
Masahiro Matsuura BRD
 Director/Board Member 54 94-03-31
Minoru Ota BRD
 Director/Board Member 65 20-05-31
Masashi Suzudo BRD
 Director/Board Member 61 16-03-31
Yasutomo Inoue BRD
 Director/Board Member 63 21-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 45,939,730 31,839,356 ( 69.31 %) 8,069,842 ( 17.57 %) 69.31 %

Shareholders

NameEquities%Valuation
KAKEN PHARMACEUTICAL CO., LTD.
17.50 %
8,041,400 17.50 % 184 M ¥
TORAY INDUSTRIES, INC.
4.993 %
2,294,000 4.993 % 52 M ¥
Silchester International Investors LLP
4.824 %
2,216,100 4.824 % 51 M ¥
Japan Agricultural Cooperatives Group
4.012 %
1,843,000 4.012 % 42 M ¥
MIZUHO FINANCIAL GROUP, INC.
3.209 %
1,474,000 3.209 % 34 M ¥
KYORIN PHARMACEUTICAL CO., LTD.
1.855 %
852,000 1.855 % 19 M ¥
Azimut Capital Management SGR SpA
1.241 %
570,000 1.241 % 13 M ¥
KAJIMA CORPORATION
1.104 %
507,010 1.104 % 12 M ¥
SEIKAGAKU CORPORATION
1.094 %
502,500 1.094 % 11 M ¥
THE SHIGA BANK, LTD.
0.8359 %
384,000 0.8359 % 9 M ¥

Holdings

NameEquities%Valuation
KAKEN PHARMACEUTICAL CO., LTD.
17.50%
 8,041,400 17.50% 183,786,760 $
FUYO GENERAL LEASE CO., LTD.
1.00%
 302,000 1.00% 27,457,266 $
KIKKOMAN CORPORATION
0.19%
 1,840,000 0.19% 23,938,418 $
KYORIN PHARMACEUTICAL CO., LTD.
2.48%
 1,602,000 2.48% 19,180,185 $
TORAY INDUSTRIES, INC.
0.21%
 3,406,000 0.21% 16,655,851 $
SEIKAGAKU CORPORATION
2.12%
 1,207,000 2.12% 6,100,999 $
MEDIPAL HOLDINGS CORPORATION
0.17%
 380,838 0.17% 5,837,946 $
IWATANI CORPORATION
0.17%
 100,200 0.17% 5,655,346 $
NISSAN CHEMICAL CORPORATION
0.10%
 134,700 0.10% 5,095,362 $
MIZUHO FINANCIAL GROUP, INC.
0.01%
 214,400 0.01% 4,315,057 $

Company contact information

Kaken Pharmaceutical Co., Ltd.

2-28-8 Honkomagome Bunkyo-Ku

113-8650, Tokyo

+

http://www.kaken.co.jp
address Kaken Pharmaceutical Co., Ltd.(4521)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Kaken Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3,407 JPY
Average target price
3,500 JPY
Spread / Average Target
+2.73%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
KAKEN PHARMACEUTICAL CO., LTD. Stock Kaken Pharmaceutical Co., Ltd.
+1.55% 820M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4521 Stock
  4. Company Kaken Pharmaceutical Co., Ltd.